. (OPTR)
$12.78 - (-)
Market Cap: -
As of 09/16/16 12:00 AM EDT. Market closed.
. (OPTR)
$12.78
- (-)
Market Cap: -
As of 09/16/16 12:00 AM EDT. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$12.78
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$12.78
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Schaum Meredith | Gen Counsel and Chief Comp Off | Oct 24, 2013 | Option Exercise | $10.75 | 2,937 | 31,573 | 0 | Oct 28, 2013, 07:51 PM |
| Sirota Eric | Chief Operating Officer | Oct 24, 2013 | Option Exercise | $10.75 | 12,129 | 130,387 | 0 | Oct 28, 2013, 07:39 PM |
| Webster Stephen W | Chief Financial Officer | Oct 24, 2013 | Option Exercise | $10.75 | 25,000 | 268,750 | 16,666 | Oct 28, 2013, 05:57 PM |
| Gorbach MD Sherwood | SVP, Chief Scientific Officer | Oct 24, 2013 | Option Exercise | $10.75 | 42,219 | 453,854 | 2,333 | Oct 28, 2013, 05:42 PM |
| MCKINNELL HENRY A | CEO and Chairman of the Board | Oct 24, 2013 | Option Exercise | $10.75 | 35,000 | 376,250 | 25,000 | Oct 28, 2013, 05:10 PM |
| Newman Stephen L | Director | Oct 24, 2013 | Option Exercise | $10.75 | 7,500 | 80,625 | 0 | Oct 28, 2013, 04:50 PM |
| GREBOW PETER E | Director | Oct 24, 2013 | Option Exercise | $10.75 | 15,000 | 161,250 | 7,500 | Oct 28, 2013, 03:52 PM |
| ZERBE ROBERT L MD | Director | Oct 24, 2013 | Option Exercise | $10.75 | 15,000 | 161,250 | 7,500 | Oct 28, 2013, 03:22 PM |
| AUERBACH MARK | Director | Oct 24, 2013 | Option Exercise | $10.75 | 20,000 | 215,000 | 10,000 | Oct 28, 2013, 03:05 PM |
| Chang Michael N | Director | Oct 24, 2013 | Option Exercise | $10.75 | 441,761 | 4,748,931 | 0 | Oct 28, 2013, 02:43 PM |
| Chang Michael N | Director | Oct 24, 2013 | Option Exercise | $10.75 | 1,026,956 | 11,039,777 | 0 | Oct 28, 2013, 02:43 PM |
| CHANG JOSEPH Y | Director | Oct 24, 2013 | Option Exercise | $10.75 | 46,154 | 496,156 | 0 | Oct 28, 2013, 02:20 PM |
| CHANG JOSEPH Y | Director | Oct 24, 2013 | Option Exercise | $10.75 | 17,500 | 188,125 | 7,500 | Oct 28, 2013, 02:20 PM |
| ALTIG ANTHONY E | Director | Oct 24, 2013 | Option Exercise | $10.75 | 20,000 | 215,000 | 15,000 | Oct 25, 2013, 05:24 PM |
| Chang Michael N | Director | Sep 04, 2013 | Option Exercise | $8.59 | 178,000 | 1,529,480 | 1,026,956 | Sep 06, 2013, 01:40 PM |
| Chang Michael N | Director | Sep 04, 2013 | Option Exercise | $11.41 | 9,000 | 102,690 | 441,761 | Sep 06, 2013, 01:40 PM |
| Chang Michael N | Director | Sep 04, 2013 | Option Exercise | $8.78 | 94,615 | 830,515 | 432,761 | Sep 06, 2013, 01:40 PM |
| Schaum Meredith | Gen.Counsel and Chief Comp Off | May 15, 2013 | Option Exercise | $7.53 | 1,789 | 13,473 | 1,789 | May 17, 2013, 07:29 PM |
| Chang Michael N | Director | Apr 23, 2013 | Option Exercise | $1.08 | 117,263 | 127,043 | 848,956 | Apr 25, 2013, 12:14 PM |
| Chang Michael N | Director | Apr 09, 2013 | Option Exercise | $12.34 | 103,125 | 1,272,563 | 731,693 | Apr 11, 2013, 01:31 PM |
| LICHTINGER PEDRO | Former CEO | Apr 08, 2013 | Option Exercise | $12.69 | 148,000 | 1,877,680 | 252,078 | Apr 10, 2013, 09:59 PM |
| LICHTINGER PEDRO | Former CEO | Apr 08, 2013 | Sale | $14.69 | 148,000 | 2,173,991 | 194,078 | Apr 10, 2013, 09:59 PM |
| Chang Michael N | Director | Apr 03, 2013 | Option Exercise | $12.34 | 145,312 | 1,793,150 | 628,568 | Apr 05, 2013, 08:01 PM |
| LICHTINGER PEDRO | CEO and President | Nov 08, 2012 | Buy | $9.08 | 11,000 | 99,847 | 104,078 | Nov 19, 2012, 07:31 PM |
| CHANG JOSEPH Y | Director | Jun 11, 2012 | Option Exercise | $0.65 | 3,461 | 2,250 | 105,767 | Jun 20, 2012, 08:42 PM |
| CHANG JOSEPH Y | Director | Jun 11, 2012 | Sale | $15.30 | 3,461 | 52,953 | 102,306 | Jun 20, 2012, 08:42 PM |
| Papaz Gregory E. | SVP, Commercial Operations | May 15, 2012 | Option Exercise | $9.72 | 998 | 9,705 | 2,592 | May 17, 2012, 01:58 PM |
| Gorbach MD Sherwood | SVP, Chief Medical Officer | May 15, 2012 | Option Exercise | $9.72 | 531 | 5,163 | 38,719 | May 17, 2012, 01:38 PM |
| LICHTINGER PEDRO | CEO and President | May 15, 2012 | Option Exercise | $9.72 | 2,185 | 21,247 | 93,078 | May 17, 2012, 01:23 PM |
| Shue Youe Kong | VP, Clinical Development | Nov 15, 2011 | Option Exercise | $9.72 | 1,186 | 11,533 | 94,230 | Nov 17, 2011, 03:09 PM |
| Prunty John D | CFO and SVP, Finance | Nov 15, 2011 | Option Exercise | $9.72 | 559 | 5,436 | 12,985 | Nov 17, 2011, 02:53 PM |
| Papaz Gregory E. | SVP, Commercial Operations | Nov 15, 2011 | Option Exercise | $9.72 | 1,594 | 15,500 | 1,594 | Nov 17, 2011, 02:45 PM |
| LICHTINGER PEDRO | CEO and President | Nov 15, 2011 | Option Exercise | $9.72 | 173 | 1,682 | 90,893 | Nov 17, 2011, 02:31 PM |
| Chang Michael N | Director | Nov 15, 2011 | Option Exercise | $9.72 | 530 | 5,154 | 338,146 | Nov 17, 2011, 02:09 PM |
| Che Tessie M | COO and SVP | Nov 15, 2011 | Option Exercise | $9.72 | 530 | 5,154 | 338,146 | Nov 17, 2011, 01:55 PM |
| ALTIG ANTHONY E | Director | Aug 09, 2011 | Buy | $7.44 | 5,000 | 37,213 | 5,000 | Aug 09, 2011, 07:32 PM |
| LICHTINGER PEDRO | CEO and President | Aug 04, 2011 | Buy | $8.98 | 25,000 | 224,450 | 90,720 | Aug 04, 2011, 05:46 PM |
| LICHTINGER PEDRO | CEO and President | Jun 30, 2011 | Option Exercise | $11.89 | 21,000 | 249,690 | 65,720 | Jul 01, 2011, 11:47 AM |
| LICHTINGER PEDRO | CEO and President | May 27, 2011 | Option Exercise | $12.34 | 20,000 | 246,800 | 44,720 | Jun 01, 2011, 01:30 PM |
| Shue Youe Kong | VP, Clinical Development | May 16, 2011 | Option Exercise | $7.71 | 1,484 | 11,441 | 93,044 | May 17, 2011, 04:51 PM |
| Prunty John D | CFO and SVP | May 16, 2011 | Option Exercise | $7.71 | 1,928 | 14,864 | 12,426 | May 17, 2011, 04:43 PM |
| LICHTINGER PEDRO | CEO and President | May 16, 2011 | Option Exercise | $7.71 | 2,500 | 19,274 | 24,720 | May 17, 2011, 04:00 PM |
| Chang Michael N | Director | May 16, 2011 | Option Exercise | $7.71 | 1,971 | 15,195 | 337,616 | May 17, 2011, 03:42 PM |
| Che Tessie M | COO and SVP | May 16, 2011 | Option Exercise | $7.71 | 1,971 | 15,195 | 337,616 | May 17, 2011, 01:49 PM |
| Che Tessie M | COO and SVP | Apr 25, 2011 | Option Exercise | $1.08 | 100,000 | 108,340 | 478,256 | Apr 27, 2011, 07:15 PM |
| Chang Michael N | Director | Apr 25, 2011 | Option Exercise | $1.08 | 100,000 | 108,340 | 478,256 | Apr 27, 2011, 06:05 PM |
| LICHTINGER PEDRO | President and CEO | Feb 02, 2011 | Option Exercise | $12.34 | 20,000 | 246,800 | 22,200 | Mar 22, 2011, 05:36 PM |
| Shue Youe Kong | VP, Clinical Development | Nov 15, 2010 | Option Exercise | $7.71 | 1,453 | 11,202 | 91,560 | Nov 16, 2010, 06:45 PM |
| Shue Youe Kong | VP, Clinical Development | Nov 15, 2010 | Option Exercise | $7.71 | 1,453 | 11,202 | 91,560 | Nov 16, 2010, 06:45 PM |
| Frapaise Francois-Xavier | Chief Scientific Officer | Nov 15, 2010 | Option Exercise | $7.71 | 1,305 | 10,061 | 4,211 | Nov 16, 2010, 06:22 PM |
| Frapaise Francois-Xavier | Chief Scientific Officer | Nov 15, 2010 | Option Exercise | $7.71 | 1,305 | 10,061 | 4,211 | Nov 16, 2010, 06:22 PM |
| Prunty John D | CFO and VP, Finance | Nov 16, 2010 | Option Exercise | $7.71 | 1,303 | 10,045 | 10,498 | Nov 16, 2010, 06:05 PM |
| Prunty John D | CFO and VP, Finance | Nov 16, 2010 | Option Exercise | $7.71 | 1,303 | 10,045 | 10,498 | Nov 16, 2010, 06:05 PM |
| LICHTINGER PEDRO | CEO and President | Nov 15, 2010 | Option Exercise | $7.71 | 2,220 | 17,115 | 2,220 | Nov 16, 2010, 05:23 PM |
| LICHTINGER PEDRO | CEO and President | Nov 15, 2010 | Option Exercise | $7.71 | 2,220 | 17,115 | 2,220 | Nov 16, 2010, 05:23 PM |
| Chang Michael N | Director | Nov 15, 2010 | Option Exercise | $7.71 | 1,075 | 8,288 | 335,645 | Nov 16, 2010, 04:35 PM |
| Chang Michael N | Director | Nov 15, 2010 | Option Exercise | $7.71 | 1,075 | 8,288 | 378,256 | Nov 16, 2010, 04:35 PM |
| Che Tessie M | COO and SVP | Nov 15, 2010 | Option Exercise | $7.71 | 1,075 | 8,288 | 335,645 | Nov 16, 2010, 02:51 PM |
| Che Tessie M | COO and SVP | Nov 15, 2010 | Option Exercise | $7.71 | 1,075 | 8,288 | 335,645 | Nov 16, 2010, 02:51 PM |
| Shue Youe Kong | VP, Clinical Development | Aug 30, 2010 | Option Exercise | $1.83 | 6,298 | 11,510 | 90,107 | Sep 01, 2010, 04:55 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Schaum Meredith | Gen Counsel and Chief Comp Off | 10/24/2013 | 31,573 |
| Sirota Eric | Chief Operating Officer | 10/24/2013 | 130,387 |
| Webster Stephen W | Chief Financial Officer | 10/24/2013 | 268,750 |
| Gorbach MD Sherwood | SVP, Chief Scientific Officer | 10/24/2013 | 453,854 |
| MCKINNELL HENRY A | CEO and Chairman of the Board | 10/24/2013 | 376,250 |
| Newman Stephen L | Director | 10/24/2013 | 80,625 |
| GREBOW PETER E | Director | 10/24/2013 | 161,250 |
| ZERBE ROBERT L MD | Director | 10/24/2013 | 161,250 |
| AUERBACH MARK | Director | 10/24/2013 | 215,000 |
| Chang Michael N | Director | 10/24/2013 | 4,748,931 |
| Chang Michael N | Director | 10/24/2013 | 11,039,777 |
| CHANG JOSEPH Y | Director | 10/24/2013 | 496,156 |
| CHANG JOSEPH Y | Director | 10/24/2013 | 188,125 |
| ALTIG ANTHONY E | Director | 10/24/2013 | 215,000 |
| Chang Michael N | Director | 09/04/2013 | 1,529,480 |
| Chang Michael N | Director | 09/04/2013 | 102,690 |
| Chang Michael N | Director | 09/04/2013 | 830,515 |
| Schaum Meredith | Gen.Counsel and Chief Comp Off | 05/15/2013 | 13,473 |
| Chang Michael N | Director | 04/23/2013 | 127,043 |
| Chang Michael N | Director | 04/09/2013 | 1,272,563 |
| LICHTINGER PEDRO | Former CEO | 04/08/2013 | 1,877,680 |
| LICHTINGER PEDRO | Former CEO | 04/08/2013 | 2,173,991 |
| Chang Michael N | Director | 04/03/2013 | 1,793,150 |
| LICHTINGER PEDRO | CEO and President | 11/08/2012 | 99,847 |
| CHANG JOSEPH Y | Director | 06/11/2012 | 2,250 |
| CHANG JOSEPH Y | Director | 06/11/2012 | 52,953 |
| Papaz Gregory E. | SVP, Commercial Operations | 05/15/2012 | 9,705 |
| Gorbach MD Sherwood | SVP, Chief Medical Officer | 05/15/2012 | 5,163 |
| LICHTINGER PEDRO | CEO and President | 05/15/2012 | 21,247 |
| Shue Youe Kong | VP, Clinical Development | 11/15/2011 | 11,533 |
| Prunty John D | CFO and SVP, Finance | 11/15/2011 | 5,436 |
| Papaz Gregory E. | SVP, Commercial Operations | 11/15/2011 | 15,500 |
| LICHTINGER PEDRO | CEO and President | 11/15/2011 | 1,682 |
| Chang Michael N | Director | 11/15/2011 | 5,154 |
| Che Tessie M | COO and SVP | 11/15/2011 | 5,154 |
| ALTIG ANTHONY E | Director | 08/09/2011 | 37,213 |
| LICHTINGER PEDRO | CEO and President | 08/04/2011 | 224,450 |
| LICHTINGER PEDRO | CEO and President | 06/30/2011 | 249,690 |
| LICHTINGER PEDRO | CEO and President | 05/27/2011 | 246,800 |
| Shue Youe Kong | VP, Clinical Development | 05/16/2011 | 11,441 |
| Prunty John D | CFO and SVP | 05/16/2011 | 14,864 |
| LICHTINGER PEDRO | CEO and President | 05/16/2011 | 19,274 |
| Chang Michael N | Director | 05/16/2011 | 15,195 |
| Che Tessie M | COO and SVP | 05/16/2011 | 15,195 |
| Che Tessie M | COO and SVP | 04/25/2011 | 108,340 |
| Chang Michael N | Director | 04/25/2011 | 108,340 |
| LICHTINGER PEDRO | President and CEO | 02/02/2011 | 246,800 |
| Shue Youe Kong | VP, Clinical Development | 11/15/2010 | 11,202 |
| Shue Youe Kong | VP, Clinical Development | 11/15/2010 | 11,202 |
| Frapaise Francois-Xavier | Chief Scientific Officer | 11/15/2010 | 10,061 |
| Frapaise Francois-Xavier | Chief Scientific Officer | 11/15/2010 | 10,061 |
| Prunty John D | CFO and VP, Finance | 11/16/2010 | 10,045 |
| Prunty John D | CFO and VP, Finance | 11/16/2010 | 10,045 |
| LICHTINGER PEDRO | CEO and President | 11/15/2010 | 17,115 |
| LICHTINGER PEDRO | CEO and President | 11/15/2010 | 17,115 |
| Chang Michael N | Director | 11/15/2010 | 8,288 |
| Chang Michael N | Director | 11/15/2010 | 8,288 |
| Che Tessie M | COO and SVP | 11/15/2010 | 8,288 |
| Che Tessie M | COO and SVP | 11/15/2010 | 8,288 |
| Shue Youe Kong | VP, Clinical Development | 08/30/2010 | 11,510 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...